The ESC M&PD meeting brings together the world's experts working to improve the treatment of myocarditis and pericarditis.Presentation to provide…
CelLBxHealth presents proof-of-concept study using Roche Tissue Diagnostics' workflow at world-leading drug development conferenceParsortix platform shown to be compatible with…
Group revenues of € 535.1 m ((7.1)%); Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec…
Third quarter revenue increased 15% year-over-year to $44.2 million Commercial Cell & Gene Therapy revenue increased 36% year-over-year to $8.3…
NEW YORK, Nov. 4, 2025 /PRNewswire/ -- The Global Healthcare Analytics Market is poised for exponential expansion, rising from USD 42.96 billion…
Research sheds light on health outcomes and insurance coverage for patients treated with GLP-1s, and how technology is innovating obesity…
The DEA's Double Standard: Raiding Cartels While Blocking CuresThe time has come for Cole's DEA to separate crime from science,…
Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter! ANN ARBOR, MI / ACCESS Newswire…
Calgary, Alberta--(Newsfile Corp. - November 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), the leading…
NEW CASTLE, Del., Nov. 4, 2025 /PRNewswire/ -- IgniteData, a leader in intelligent clinical trial data automation, today announced the final…